Navigation Links
CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
Date:11/19/2007

Positive Opinion Coincides with Expansion of The Medicines Company into

Europe

PARSIPPANY, N.J. and ZURICH, Switzerland, Nov. 19 /PRNewswire/ -- The Medicines Company (Nasdaq: MDCO) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) adopted a positive opinion to extend the indication for Angiox(R) (bivalirudin) to adult patients with acute coronary syndromes (ACS) planned for urgent or early intervention, specifically patients with unstable angina (UA) or non-ST segment elevation myocardial infarction (NSTEMI). Angiox should be administered with aspirin and clopidogrel. Angiox is an anticoagulant currently approved in Europe for use in patients undergoing percutaneous coronary interventions (PCI), commonly referred to as angioplasty.

The positive opinion is based on results from the ACUITY trial of 13,819 patients with ACS, which found that Angiox with or without a glycoprotein IIb/IIIa inhibitor (GPI) resulted in similar rates of ischemic clinical outcomes compared to standard therapy of heparin (unfractionated or enoxaparin) plus a GPI. Importantly, Angiox monotherapy was associated with 47% less major bleeding compared to standard therapy. Of the patients enrolled in ACUITY, 35% were treated at European hospitals.

"The CHMP recommendation will accelerate our efforts to establish Angiox as the preferred anti-thrombotic strategy for patients who require PCI for coronary artery disease in Europe," noted John Kelley, President and Chief Operating Officer of The Medicines Company. "We believe the European Commission will approve expanded use of Angiox in ACS patients during the first quarter of 2008,
'/>"/>

SOURCE The Medicines Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
2. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
3. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
4. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
5. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
6. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
7. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
8. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
9. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
10. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
11. BioMosaics Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015 Perrigo Company plc (NYSE: PRGO ... Healthcare Products®," today announced that it has completed the ... a cash and equity transaction valued at approximately €3.8 ... debt. Sellers are Marc Coucke , Waterland Private ...   "The combination of Perrigo and ...
(Date:3/30/2015)... 30, 2015  Caris Life Sciences® today announced the ... pathways may have potentially significant benefit in a select ... were highlighted today in an oral presentation in a ... 2015 Annual Meeting on Women,s Cancer in ... one of four presented at the annual meeting that ...
(Date:3/30/2015)... , March 30, 2015  Orexigen Therapeutics, ... Tom Cannell has joined as Chief ... commercialization of Contrave® /Mysimba™ (naltrexone HCl / bupropion ... of Orexigen,s global commercial strategy, assuming responsibilities previously ... leading Orexigen,s commercial effort through the U.S. launch ...
Breaking Medicine Technology:Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10
... 2012 Amsterdam Molecular Therapeutics (Euronext: AMT), ... announced that the Extraordinary General Meeting (EGM) of shareholders ... with the EGM Notice of February 17, 2012. At ... the substantial corporate restructuring and financing transaction, which will ...
... DIEGO, March 30, 2012  Genalyte, Inc., a life ... technology, today announced completion of an $11.8 million ... Claremont Creek Ventures and private investors from Genalyte,s ... financing.  Genalyte intends to use the new funds ...
Cached Medicine Technology:Amsterdam Molecular Therapeutics Announces Results of Extraordinary General Meeting 2Genalyte, Inc. Completes $12 Million Series B Financing to Commercialize Its Maverick™ Next-Generation Multiplexing Platform 2Genalyte, Inc. Completes $12 Million Series B Financing to Commercialize Its Maverick™ Next-Generation Multiplexing Platform 3
(Date:3/30/2015)... March 30, 2015 Foundations Recovery Network, ... announce the start of its 41st national conference by ... McGonigal, and former Congressman Patrick J. Kennedy as keynote ... being held in San Diego, CA, March 30 - ... national conference brings together leading experts specializing in the ...
(Date:3/30/2015)... Falls Church, VA (PRWEB) March 30, 2015 ... aseptic fill sites and flexible biological manufacturing plants. This ... trends in the business. , This has forced facilities ... lifespan. , The existing facilities have been forced ... have undergone a change of ownership. , Most of ...
(Date:3/30/2015)... 2015 Good Shepherd Children’s Home announces 53rd ... in Murfreesboro provides a Christian-based home, the children learn biblical ... his special plan for their life. , A day ... begins as, one-by-one, the children begin to awake and prepare ... alarm continues to buzz. Sleepily, she crawls out of ...
(Date:3/30/2015)... KIND LED’s suite of LED grow lights ... 2015. The excellent value and product features of the KIND ... position in the race for the best LED grow light ... suite of grow lights is the 12 band perfect ... (PAR) wavelengths that plants are most likely to use during ...
(Date:3/30/2015)... Dr. Jeff Farmer now offers mini dental implants ... is placed into the bone, usually without surgery, and the ... into place. For those having trouble with dentures or partials ... solution. Thousands of patients around the world now enjoy secure ... is all made possible by mini dental implants that are ...
Breaking Medicine News(10 mins):Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 3Health News:Good Shepherd Children’s Home Announces 53rd Year of Providing a Safe-Haven for Children in Need 2Health News:Best LED Grow Lights of 2015 Are Being Led By KIND LED 2Health News:Dr. Jeffrey Farmer A Murfreesboro Dentist Announces New High Tech Dentistry 2
... dangerous environments, females looking for a mate run great ... the Smithsonian Tropical Research Institute in Panama present a ... issue of the Public Library of Science. The researchers ... helps them avoid their predators as they sequentially visit ...
... Amidst rising incidence of tuberculosis in Britain, senior doctors ... be screened for the disease. ,The ... Africa. ,The Observer reported Sunday that two ... that public health officials were failing to come to ...
... intervals in the music of many human cultures is rooted ... according to researchers at the Duke University Center for Cognitive ... sound right to our ears because of the way our ... said Dale Purves, the George Barth Geller Professor for Research ...
... Pakistani authorities have intensified monitoring of over 800 poultry farms ... five poultry farms there, an official said Saturday. ... in three farms May 22 and in two other farms ... state media reported, quoting Livestock Commissioner R.H Usmani. ...
... papers selected for publication in the August 2007 issue ... that become pregnant before they have achieved their full ... nourishment for their fetuses to develop without physical deficits. ... managing pregnancies of adolescent human females, who, in increasing ...
... team of scientists has discovered the secret behind inflorescence, ... branching structures. , ,Using mathematical models ... the evolutionary processes that work together to create inflorescences ... ,"This is a unifying theory that provides an explanation ...
Cached Medicine News:Health News:Scientists Report New Take on Sexual Signaling 2Health News:Essential Tones of Music Rooted in Human Speech 2Health News:Essential Tones of Music Rooted in Human Speech 3Health News:Sheep Offer Model for Undernourishment in Pregnant Teen Girls 2
Steroid eluting pacemaker leads...
... family of temporary sensing and pacing leads. ... in temporary pacing leads and improved upon ... use and less traumatic to heart tissue. ... Pacing Lead is designed for temporary atrial ...
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Medicine Products: